Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      Homepharmaceuticals

      pharmaceuticals

      SpringWorks Increases License Agreement With GSK for Myeloma Combination and Receives $75 Million in Investment
      Investing News

      SpringWorks Increases License Agreement With GSK for Myeloma Combination and Receives $75 Million in Investment

      September 7, 2022
      Pacira Achieves Major Objectives, In a Late-Stage Experiment to Broaden the Indication for Local Anesthetics.
      Investing News

      Pacira Achieves Major Objectives, In a Late-Stage Experiment to Broaden the Indication for Local Anesthetics.

      September 7, 2022
      Roche will pay $250 million upfront to purchase Good Therapeutics in order to expand its immuno-oncology offering
      Investing News

      Roche will pay $250 million upfront to purchase Good Therapeutics in order to expand its immuno-oncology offering

      September 7, 2022
      Iveric Drives Apellis Lower as Street Responds to Phase 3 Results for the GA Candidate
      Investing News

      Iveric Drives Apellis Lower as Street Responds to Phase 3 Results for the GA Candidate

      September 6, 2022
      Point Biopharma Drops 28% After Phase 3 Data for a Prostate Cancer Candidate
      Investing News

      Point Biopharma Drops 28% After Phase 3 Data for a Prostate Cancer Candidate

      September 6, 2022
      GSK announces an upcoming FDA AdCom conference on the treatment of renal disease
      Investing News

      GSK announces an upcoming FDA AdCom conference on the treatment of renal disease

      September 6, 2022
      Eiger Drops 21% While the Regulatory Pathway for COVID-19 Therapy Is Unknown
      Investing News

      Eiger Drops 21% While the Regulatory Pathway for COVID-19 Therapy Is Unknown

      September 6, 2022
      CVS Health Expands in Home Healthcare by Acquiring Signify Health
      Investing News

      CVS Health Expands in Home Healthcare by Acquiring Signify Health

      September 6, 2022
      What Caused the Moderna Shares DropToday?
      Trading Tips

      What Caused the Moderna Shares DropToday?

      September 6, 2022
      atai Life Sciences to Participate in September Investor Events
      Other

      atai Life Sciences to Participate in September Investor Events

      September 6, 2022
      « 1 … 10 11 12 13 14 … 18 »

       

      LATEST NEWS

      • Investing News Lucid Motors Q4 2025 Financial Report
      • Investing News Workday Q4 Earnings: Key Insights
      • Investing News Home Depot Q4 2025 Earnings Analysis
      • Investing News Stocks Rally Amid AI Sell-Off
      • Investing News Walmart’s Strong Q4 2026 Performance

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026